Effects of antihistamines on innate immune responses to severe bacterial infection in mice

International Archives of Allergy and Immunology

Volumn 155, Issue 4, 2011, Pages 355-360

  Metz, Martin ^a   Doyle, Elizabeth ^a   Bindslev Jensen, Carsten ^b   Watanabe, Takeshi ^c   Zuberbier, Torsten ^a   Maurer, Marcus ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Allergy; Histamine; Mast cell; Sepsis; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; DESLORATADINE; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR ANTAGONIST; THIOPERAMIDE;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; GENE TARGETING; HISTOPATHOLOGY; INNATE IMMUNITY; MAST CELL; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PERITONITIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR GENE; SEPSIS;

ANIMALS; ANTI-ALLERGIC AGENTS; BACTERIAL INFECTIONS; DIPHENHYDRAMINE; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HISTAMINE H3 ANTAGONISTS; HUMANS; IMMUNITY, INNATE; LORATADINE; MICE; MICE, INBRED C57BL; PERITONITIS; PIPERIDINES; RECEPTORS, HISTAMINE; SEPSIS;

EID: 79951853150     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000321614     Document Type: Article

References (22)

1. Thurmond RL, Gelfand EW, Dunford PJ: The role of histamine H 1 and H 4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov 2008; 7: 41-53.
2. Schneider E, Rolli-Derkinderen M, Arock M, Dy M: Trends in histamine research: New functions during immune responses and hematopoiesis. Trends Immunol 2002; 23: 255-263. (Pubitemid 34499563)
3. Stempel DA, Woolf R: The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2002; 2: 223-230.
4. Church MK, Maurer M, Simons FE, Bindslev- Jensen C, van Cauwenberge P, Bousquet J, Holgate ST, Zuberbier T: Risk of first-generation H 1 -antihistamines: A GA 2 LEN position paper. Allergy 2010; 65: 459-466.
5. St. Peter SD, Sharp SW, Ostlie DJ: Influence of histamine receptor antagonists on the outcome of perforated appendicitis: Analysis from a prospective trial. Arch Surg 2010; 145: 143-146.
6. Handley SA, Dube PH, Miller VL: Histamine signaling through the H 2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc Natl Acad Sci USA 2006; 103: 9268-9273. (Pubitemid 43902567)
7. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K, Watanabe T, Watanabe T: Impaired locomotor activity and exploratory behavior in mice lacking histamine H 1 receptors. Proc Natl Acad Sci USA 1996; 93: 13316-13320. (Pubitemid 26382813)
8. Bell JK, McQueen DS, Rees JL: Involvement of histamine H 4 and H 1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004; 142: 374-380. (Pubitemid 38750189)
9. Girard P, Pansart Y, Coppe MC, Verniers D, Gillardin JM: Role of the histamine system in nefopam-induced antinociception in mice. Eur J Pharmacol 2004; 503: 63-69. (Pubitemid 39445942)
10. Shibamoto T, Liu W, Cui S, Zhang W, Takano H, Kurata Y: PAF, rather than histamine, participates in mouse anaphylactic hypotension. Pharmacology 2008; 82: 114-120.
11. Wentzel P, Eriksson UJ: Ethanol-induced fetal dysmorphogenesis in the mouse is diminished by high antioxidative capacity of the mother. Toxicol Sci 2006; 92: 416-422. (Pubitemid 44018958)
12. Yang S, Healey MC: The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum. J Parasitol 1993; 79: 626-630. (Pubitemid 23249757)
13. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ: Mast cells promote homeostasis by limiting endothelin- 1-induced toxicity. Nature 2004; 432: 512-516. (Pubitemid 39576533)
14. Orinska Z, Maurer M, Mirghomizadeh F, Bulanova E, Metz M, Nashkevich N, Schiemann F, Schulmistrat J, Budagian V, Giron- Michel J, Brandt E, Paus R, Bulfone-Paus S: IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 2007; 13: 927-934. (Pubitemid 47222042)
15. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36.
16. Schmidt C, Kurt B, Hocherl K, Bucher M: Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis. Shock 2009; 32: 239-246.
17. Piliponsky AM, Chen CC, Grimbaldeston MA, Burns-Guydish SM, Hardy J, Kalesnikoff J, Contag CH, Tsai M, Galli SJ: Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 2010; 176: 926-938.
18. Piliponsky AM, Chen CC, Nishimura T, Metz M, Rios EJ, Dobner PR, Wada E, Wada K, Zacharias S, Mohanasundaram UM, Faix JD, Abrink M, Pejler G, Pearl RG, Tsai M, Galli SJ: Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 2008; 14: 392-398. (Pubitemid 351499391)
19. Siebenhaar F, Magerl M, Peters EM, Hendrix S, Metz M, Maurer M: Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J Allergy Clin Immunol 2008; 121: 955-961.
20. Metz M, Maurer M: Mast cells - key effector cells in immune responses. Trends Immunol 2007; 28: 234-241. (Pubitemid 46654869)
21. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301: 2120-2128.
22. Simons FE: Non-cardiac adverse effects of antihistamines (H 1 -receptor antagonists). Clin Exp Allergy 1999; 29(suppl 3):125-132. (Pubitemid 29333346)